Public-registry site landscape for NCT02798406, a Brain Cancer study sponsored by DNAtrix, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT02798406 (registry record) |
| Sponsor | DNAtrix, Inc. |
| Condition(s) | Brain Cancer; Brain Neoplasm; Glioma; Glioblastoma |
| Phase | PHASE2 |
| Listed sites | 15 |
| Site countries | United States, Canada |
Eichor generates a preliminary site-risk snapshot for NCT02798406 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →